Hyperuricemia and gout in renal transplant recipients

Renal Failure

Volumn 24, Issue 3, 2002, Pages 361-367

  Abdelrahman, Mohammad ^a   Rafi, Ali ^a   Ghacha, Reda ^a   Youmbissi, J T ^a   Qayyum, Tahir ^a   Karkar, Ayman ^a  

^a NONE   (Saudi Arabia)

Author keywords

Cyclosporine; Gout; Hyperuricemia; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; BIOLOGICAL MARKER; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GOUT; HUMAN; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PREVALENCE; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; EPIDEMIOLOGY; FOLLOW UP; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS; TIME; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; CAUSALITY; COMPARATIVE STUDY; CREATININE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GOUT; HUMAN; HYPERURICEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; PREVALENCE; RETROSPECTIVE STUDIES; STATISTICS; TIME FACTORS; TREATMENT OUTCOME; URIC ACID; HUMANS; MIDDLE AGED;

EID: 0036022110     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120005370     Document Type: Article

References (21)

1. Cyclosporine-induced hyperuricemia and gout
2. Cyclosporine-induced hyperuricemia after renal transplant: Clinical characteristics and mechanisms
3. Hyperuricemia and gout in renal allograft recipients
4. Cyclosporine-induced hyperuricemia and gout in renal transplants
5. Hyperuricemia after renal transplantation
6. The incidence of gout n renal transplant recipients
7. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years
8. Renal transplant-associated hyperuricemia and gout
9. Cyclosporine inhibits renal uric acid transport in renal transplants not in children treated for nephritic syndrome
10. The mechanism of hyperuricemia in cyclosporine treated renal transplant recipients
11. Glomerular and tubular function in renal transplant patients treated with and without cyclosporin A
12. Impairment of tubular secretion of urate in renal transplant patients on cyclosporine
13. Renal handling of uric acid under cycloporin A treatment
14. Effect of nifedipine on tubular handling of uric acid in transplanted kidney on cyclosporine A treatment
15. Tubular effects of cyclosporine in pediatric renal transplant recipients
16. Mechanisms of hyperuricemia in cyclosporine-treated renal transplanted children
17. The incidence and management of osteoporosis, gout and avascular necrosis in recipients of renal allografts functioning more than 20 years treated with prednisone and azathioprim
18. Natural history and etiology of hyperuricemia following pediatric renal transplantation
19. Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use
20. Gout in the heart transplant recipient: Physiologic puzzle and therapeutic challenge
21. Side effects of systemic cyclosporine in patients not undergoing transplantation